Vitality Biopharma Announces International Patent Filing for Cannabinoid Pharmaceuticals

Once concluded, IP protection extends to 2035 or longer in USA and all major markets worldwide LOS ANGELES, CA VBIO, (Marketwired Nov 9, 2016) Vitality Biopharma, Inc. (OTCQB: VBIO) ( Vitality or the Company ), a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals, and to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders, today announced the filing of an international PCT patent application, a milestone in its development of a platform of cannabinoid


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: